While some debate exists regarding whether Gal-3’s prognostic value is independent of renal and hepatic function parameters or incremental to other established biomarkers, like natriuretic peptides, its role in reflecting cardiac fibrosis and inflammation remains undisputed. Here, LGALS3 is linked to fibrosis.